Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH

    AYUSH - Page 5

    Queen of Herbs Tulsi, the natural cure for most diseases, says Patanjali

    Queen of Herbs Tulsi, the natural cure for most diseases, says Patanjali's Acharya Bal Krishan

    Ruby Khatun Khatun27 Nov 2017 9:30 AM IST
    Haridwar: 'Queen of Herbs' Tulsi is known for its healing powers.This medicinal plant is a virtual tonic for your body, is extremely beneficial and an...
    AYUSH Ministry holds review meeting to examine the draft of national policy of medicinal and aromatic plants

    AYUSH Ministry holds review meeting to examine the draft of national policy of medicinal and aromatic plants

    Ruby Khatun Khatun25 Nov 2017 10:00 AM IST
    The National Medicinal Plant Board of AYUSH Ministry along with the Medicinal & Aromatic Plants Stakeholders jointly organized a one-day review...
    Patanjali group to set up food park in Telangana

    Patanjali group to set up food park in Telangana

    Ruby Khatun Khatun19 Nov 2017 9:45 AM IST
    Hyderabad: Yoga guru Ramdev-led Patanjali group signed a MoU with the Telangana government for setting up a "large" food park in the state.TRS Lok...
    Ayurveda firm Kapiva to raise 8 million dollars

    Ayurveda firm Kapiva to raise 8 million dollars

    Ruby Khatun Khatun9 Nov 2017 9:37 AM IST
    A healthcare startup Kapiva Ayurveda is planning to raise about $8 million within a year-and-half to expand its product portfolio and invest in...
    Ayurveda witnesses global resurgence; Market size to touch 8 billion dollars by 2022: Shripad

    Ayurveda witnesses global resurgence; Market size to touch 8 billion dollars by 2022: Shripad

    Ruby Khatun Khatun18 Oct 2017 9:57 AM IST
    New Delhi: Minister of State for AYUSH Shripad Yesso Naik on Monday said a threefold increase in market size of Ayurvedic products from 2.5 billion to...
    Baba Ramdevs Patanjali Ayurved planning to invest Rs 5,000 crore this fiscal

    Baba Ramdevs Patanjali Ayurved planning to invest Rs 5,000 crore this fiscal

    Ruby Khatun Khatun9 Oct 2017 10:38 AM IST
    INDORE: Patanjali Ayurved's managing director Balkrishna said here that the company is planning to invest Rs 5,000 crore in the country in the current...
    Dabur plans subscription-based model for ayurvedic medicines

    Dabur plans subscription-based model for ayurvedic medicines

    supriya kashyap kashyap28 Sept 2017 9:07 AM IST
    New Delhi: Homegrown FMCG major Dabur is testing a subscription-based model for its ayurvedic medicines in the country, a senior company official...
    Patanjalis Balkrishna in Hurun India rich list

    Patanjali's Balkrishna in Hurun India rich list

    Ruby Khatun Khatun27 Sept 2017 12:43 PM IST
    MUMBAI: Acharya Balkrishna, the head of yoga expert Baba Ramdev-run FMCG company Patanjali and Radhakishan Damani of D-Mart have found their place...
    Patanjali Versus Dabur: HC restrains Patanjali from airing ads to promote Chyawanprash

    Patanjali Versus Dabur: HC restrains Patanjali from airing ads to promote Chyawanprash

    Ruby Khatun Khatun8 Sept 2017 1:22 PM IST
    New Delhi: The Delhi High Court on Friday ordered Baba Ramdev’s Patanjali Ayurved Ltd to stop airing advertisements to promote its brand of...
    Incentives are given to Farmers for Cultivation of Medicinal Plants: Shri Shripad Naik

    Incentives are given to Farmers for Cultivation of Medicinal Plants: Shri Shripad Naik

    Ruby Khatun Khatun14 Aug 2017 9:49 AM IST
    The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik through a written reply to a question in Lok Sabha informed that...
    53 species of medicinal plants are under threatened categories: AYUSH Minister

    53 species of medicinal plants are under threatened categories: AYUSH Minister

    Ruby Khatun Khatun13 Aug 2017 10:00 AM IST
    The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik through written reply to a question in Lok Sabha informed that 53...
    Quality standards prescribed in pharmacopoeias mandatory for manufacturing of AYUSH drugs: Shri Shripad Naik

    Quality standards prescribed in pharmacopoeias mandatory for manufacturing of AYUSH drugs: Shri Shripad Naik

    Ruby Khatun Khatun12 Aug 2017 9:40 AM IST
    The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik through a written reply to a question in Lok Sabha informed that the...
    PrevNext

    Popular Stories

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok